Outpatient Sedation Basics for Patients on GLP-1 Medications: What Non-Anesthesiologists Need to Know With more patients taking GLP-1 medications like Ozempic, Wegovy, or Trulicity for diabetes and weight loss, it's important for all providersdentists, proceduralists, and specialists who give sedation outside of operating roomsto understand how these drugs can affect their procedures.pubmed.ncbi.nlm
Patients should avoid choosing a medication based only on headline weight-loss percentages
Mental healthcare providers know that many drugs that we prescribe in psychiatry can be highly weight-gain promoting and diabetogenic and very metabolically disruptive
GLP-1 agonist drug sales increased 58.2% between December 2022 and December 2023, with Ozempic and Mounjaro driving most of that growth volume
How evidence is handled: Ingredient-level research is presented for educational context only
Pharmaceutical companies behind Ozempic, including its manufacturer Novo Nordisk, allegedly inadequately disclosed the risks of medication-induced gastroparesis and related dangers